dr. halfdanarson on investigational agents in driver-negative crc
Published 4 years ago • 49 plays • Length 0:54Download video MP4
Download video MP3
Similar videos
-
3:18
hyperhuman blueprint/ultimate all in one power/programmed field
-
15:12
horrendous vaccine injury lies
-
20:08
what's new in nets: medical (thor halfdanarson, md)
-
4:24
a team approach to ocular oncology
-
1:12
dr. lenz on choosing between regorafenib and tas-102 in crc
-
1:32
dr thorvardur halfdanarson discusses if he thinks there's a future for immunotherapy in nets
-
24:25
neuroendocrine neoplasms -thor halfdanarson
-
18:16
surgery for neuroendocrine tumors
-
5:52
patient story: net patient shares his experience with prrt (lacnets)
-
0:49
what is the conquer registry?
-
0:47
discover the power of small and safe with nanoplasmid®
-
1:15
dr. shearwood mcclelland - radiation oncology
-
1:30:15
lacnets webinar: "2022: year in review" with medical oncologist dr. thor halfdanarson
-
1:08
#stowersimpact | randal halfmann, phd
-
2:05
dr thorvardur halfdanarson outlines new, exciting developments in treatment of nets
-
1:07
dr. harshman on the protect trial in patients with locally advanced rcc
-
59:28
luncheon with the experts: thorvardur thor r halfdanarson, md
-
1:36
early hbot in brain bleeds
-
0:40
60-second stories: brian wamhoff, phd, hemoshear therapeutics
-
1:00:25
luncheon with the experts: thorvardur r. halfdanarson, md
-
21:09
08 - cumulative treatment toxicities by dr. thor halfdanarson
-
20:56
07. surveillance, maintenance, more treatments (dr. halfdanarson) - 2021 lacnets virtual conference